IRIDEX Corp (IRIX) USD0.01

Sell:$1.18Buy:$1.25$0.06 (5.17%)

Prices delayed by at least 15 minutes
Sell:$1.18
Buy:$1.25
Change:$0.06 (5.17%)
Prices delayed by at least 15 minutes
Sell:$1.18
Buy:$1.25
Change:$0.06 (5.17%)
Prices delayed by at least 15 minutes

Company Information

About this company

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Key people

Scott A. Shuda
Executive Chairman of the Board
Patrick Mercer
President, Chief Executive Officer, Chief Operating Officer, Director
Romeo R. Dizon
Chief Financial Officer
Nick Chen
Director
William M. Moore
Director
Nandini Devi
Independent Director
Beverly A. Huss
Independent Director
Click to see more

Key facts

  • EPIC
    IRIX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US4626841013
  • Market cap
    $20.48m
  • Employees
    93
  • Shares in issue
    16.79m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.